Long-acting basal insulin analog

This page covers all Long-acting basal insulin analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Insulin receptor.

Targets

Insulin receptor

Marketed (7)

• Early Glargine · The Cleveland Clinic · Diabetes
  Early Glargine is a long-acting basal insulin analog that binds to the insulin receptor to lower blood glucose by promoting glucose uptake and storage in peripheral tissues.
• Insulin Degludec 100 UNT/ML [Tresiba] · Merete Bechmann Christensen · Diabetes
  Insulin degludec is a long-acting basal insulin that binds to the insulin receptor to promote glucose uptake and utilization in peripheral tissues while suppressing hepatic glucose production.
• Basalin to Lantus · Nanjing First Hospital, Nanjing Medical University · Diabetes
  Basalin is a long-acting basal insulin analog that binds to insulin receptors to lower blood glucose by promoting glucose uptake and storage in peripheral tissues.
• Detemir or Glargine · Institut de Recherches Cliniques de Montreal · Diabetes
  Detemir and Glargine are long-acting basal insulin analogs that bind to the insulin receptor to lower blood glucose by promoting glucose uptake and storage in peripheral tissues.
• Insulin-Levemir · Novo Nordisk A/S · Diabetes
  Insulin detemir is a long-acting basal insulin that binds to the insulin receptor to facilitate glucose uptake and utilization in peripheral tissues while suppressing hepatic glucose production.
• Glargine U300 · University of Split, School of Medicine · Diabetes
  Glargine U300 is a long-acting basal insulin that binds to insulin receptors to promote glucose uptake and utilization in peripheral tissues while suppressing hepatic glucose production.
• switch NPH to glargin · Les Laboratoires des Médicaments Stériles · Diabetes
  Insulin glargine is a long-acting basal insulin that binds to insulin receptors to lower blood glucose by promoting glucose uptake and storage in peripheral tissues and suppressing hepatic glucose production.

Phase 3 pipeline (4)

• Placebo insulin icodec · Novo Nordisk A/S · Diabetes
  Insulin icodec is a long-acting basal insulin analog that binds to the insulin receptor to regulate blood glucose by promoting glucose uptake and storage.
• GZR18 · Gan & Lee Pharmaceuticals. · Diabetes
  GZR18 is a long-acting basal insulin analog designed to provide sustained glucose control in diabetes.
• Insulin Degludec Injection · Jiangsu HengRui Medicine Co., Ltd. · Diabetes
  Insulin degludec is a long-acting basal insulin that binds to the insulin receptor to promote glucose uptake and utilization in peripheral tissues while suppressing hepatic glucose production.
• Once-daily insulin detemir · Sydney Children's Hospitals Network · Diabetes
  Insulin detemir is a long-acting basal insulin that binds to the insulin receptor to lower blood glucose by promoting glucose uptake and storage in peripheral tissues while suppressing hepatic glucose production.